Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bea Balajonda"'
Autor:
Eric Thompson, Daniel Landi, Gerald Archer, Eric Lipp, Ashley Walter, Bridget Archambault, Bea Balajonda, Charlene Flahiff, Denise Jaggers, James Herndon, Evan Buckley, Kristin Schroeder, Dina Randazzo, Annick Desjardins, Margaret Johnson, Katherine Peters, Mustafa Khasraw, Michael Malinzak, Duane Michell, David Ashley, John Sampson
Publikováno v:
Neuro-Oncology
Introduction The cytomegalovirus (CMV) antigen, pp65, is ubiquitously expressed in malignant glioma and medulloblastoma but not in healthy brain. The objective of this Phase I trial (NCT03299309) was to assess the safety and feasibility of a novel pp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ae4c428db709fee1578749aa2ce7aa6
http://europepmc.org/articles/PMC8168240
http://europepmc.org/articles/PMC8168240
Autor:
John Sampson, James E. Herndon, Katherine B. Peters, Kristin Schroeder, Denise Jaggers, Eric S. Lipp, Gerald E. Archer, Duane Michell, Charlene Flahiff, Annick Desjardins, Ashley Walter, Bea Balajonda, Daniel Landi, Mustafa Khasraw, Bridget Archambault, Eric M. Thompson, Michael D. Malinzak, David M. Ashley, Evan Buckley, Margaret Johnson, Dina Randazzo
Publikováno v:
Neuro-Oncology
INTRODUCTION The cytomegalovirus (CMV) antigen, pp65, is ubiquitously expressed in malignant glioma and medulloblastoma but not in healthy brain. The objective of this Phase I trial (NCT03299309) was to assess the safety and feasibility of a novel pp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9770a8dba4bf8c65af7a5de14ad002f3
https://doi.org/10.1093/neuonc/noaa215.155
https://doi.org/10.1093/neuonc/noaa215.155
Autor:
Jyothi Menon, Phioanh L. Nghiemphu, Prianka Singh, Alexandre H. Watanabe, Trang H. Au, Hillevi Bauer, Nicole Willmarth, Alexander Marshall, Katherine B. Peters, Beata Korytowsky, Connor Willis, Howard Colman, Adam L. Cohen, Diana I. Brixner, Bea Balajonda, David D. Stenehjem, Ryan Nelson, Eli Iacob, Junjie Ma, Laura Dovek
Publikováno v:
Journal of Clinical Oncology. 36:16-16
16 Background: GBM is a largely incurable, highly aggressive cancer with high incidence of CD. Caregivers face heightened stress with loved one’s limited life expectancy and additional duties. To better understand this unique group, a survey tool w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9307348388b219cf5371d437de8545e5
https://doi.org/10.1200/jco.2018.36.34_suppl.16
https://doi.org/10.1200/jco.2018.36.34_suppl.16